Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 1 6Phase 4 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Completed 6

Sponsor Class

INDUSTRY 5NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Neoplasms 1331Breast Neoplasms 688Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 437Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 366Lymphoma, Non-Hodgkin 356Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 267Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 254Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Hodgkin Disease 193Carcinoma, Renal Cell 193Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Glioma 172Burkitt Lymphoma 172

Interventions

vilaprisan 1relugolix 1Fluconazole 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Completed × Endometriosis × Clear all
NCT06949124 2025-09-10

A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
20 enrolled

Endometriosis, Leiomyoma

NCT06969664 2025-08-19

A Trial of SHR7280 in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
16 enrolled

Endometriosis, Leiomyoma

NCT05868057 2023-12-08

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
16 enrolled

Endometriosis, Leiomyoma

NCT03411980 2019-12-03

Pharmacokinetics and Safety of Vilaprisan in Renal Impairment

Bayer

Phase 1 Completed
26 enrolled

Endometriosis, Leiomyoma

NCT02093390 2016-06-06

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

Millennium Pharmaceuticals, Inc.

Phase 1 Completed
40 enrolled 23 charts
Genitourinary

Endometriosis, Prostatic Neoplasms

NCT00090389 2008-01-25

Acupuncture for Women's Health Conditions

National Center for Complementary and Integrative Health (NCCIH)

Phase 1 Completed
50 enrolled
Gynecologic

Endometriosis, Ovarian Neoplasms, Uterine Neoplasms, Pelvic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡